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EXPERIMENTS have shown that cortisone therapy and limb exercise botlh
enhance the dissemination of the Vx2 carcinoma via the lymphatic system of the
rabbit (Stoker, 1969). Further investigations have been carried out to determine
the degree of retention of tumour cells by the normal lymph node and the effect
of these two factors on it.
Gray and Sterling (1950) developed a method for labelling red blood cells with
radio-active sodium chromate, which has been modified by Rajam, Jackson and
Black (1958) and by Selecki (1959) for use with tumour cell suspensions.
Fisher and Fisher (1967) reported the use of labelled Vx2 tumour cells to
determine their retention by the popliteal lymph node of the rabbit. They found
that, using a wide range of tumour cell inoculation size, the regional lymph node
was a very inefficient barrier to the further spread of tumour cells; the majority
of tumour cells transgressed the lymph node and most of them were deduced to
have left it by way of the venous system. These findings are difficult to reconcile
with previous experimental findings that the regional lymph node will temporarily
limit tumour growth.
MATERIALS AND METHODS
An experimental animal model was used, employing the Vx2 cancer in New
Zealand white rabbits.
Labelling of tumour cells with radio-chromate
Suspension oftumour cells were labelled with chromium-51 isotope by a method
similar to that described by Rajam et al. (1958). Sodium chromate B.P. (51Cr)
was incubated at 370 C. with continuous stirring for 1 hour with the cell suspension.
5 ,uCi activity per 107 cells. 100 mg. Ascorbic acid per 50 1pCi activity was then
added and incubation continued for a further 45 minutes. The suspension was
washed repeatedly and re-suspended in Hank's solution until less than 20% of
radio-activity remained in the supernatant fluid.
M1leasurements of radio-activity
These were made in a sodium iodide scintillation well counter of 5 ml. capacity,
comparing equal volumes of specimens; 5'Cr is an emitter of y-irradiation and
has a half life of 27-8 days.RETENTION OF TUMOUR CELLS IN LYMPH NODES
Experimental technique
A total of 107 labelled tumour cells in 1 ml. volume was injected over 25
minutes into the popliteal afferent lymphatic vessel of each rabbit, using a
technique identical to that previously described. A standard suspension was
collected simultaneously from an identical injection apparatus for comparison
of radio-activity with that of the popliteal lymph node.
The popliteal lymph node was excised either immediately after the end of the
intra-lymphatic injection or 24 hours later, carefully cleaned of surrounding fat,
and placed in a plastic tube for scintillation counting. The retention of tumour
cells was expressed as the percentage ofthe radio-activity ofthe standard solution
found in the popliteal lymph node.
E8timation8 of elution ofradio-active i8otopefrom tumour celle
The elution ofthe isotope in the living animal was studied in two ways.
(i) Millipore diffusion chambers, pore size 0 45It, were charged with labelled
tumour cells and counted; they were then implanted subcutaneously in a rabbit
for 24 hours and re-counted in the scintillation counter. The radio-activity lost
was deemed to have eluted from the tumour cells.
(ii) Estimations of the urinary excretion of isotope were made for a 24-hour
period following the injection ofradio-actively labelled tumour cells, and following
the injection of free isotope solution reduced with ascorbic acid.
Investigation ofconstancy ofdelivery from this injection apparatus showedthe
coefficient ofvariation ofthese standard suspensions to be less than 5%.
RESULTS
The elution of 5'chromiumfrom the Vx2 tumour cellB
(i) Millipore chamber8.-Twelve chambers were implanted and demonstrated
an average elution of 37% (S.D. 9.6) of radio-activity from the tumour cells in
the 24-hour period.
(ii) Urinary excretion.-Urinary excretion of 5'Cr isotope in 24-hour period
following subcutaneous injection of reduced radio-active sodium chromate
solution.
Mean value 12 rabbits: 45%.
Urinary excretion of isotope following subcutaneous injection of labelled
tumour cells.
Mean value 12 rabbits: 18%.
From these values the elution ofthe isotope from the cells is 40%.
The viability of labelled tumoUr cell 8supen8ion8
The ability oflabelled tumour cell suspensions to produce tumour growth was
investigated by subcutaneous and intralymphatic inoculation. This viability
was found to be less than that ofunlabelled tumour cell suspensions.
Route of Cell Number of Number of
administration dose inoculations tumour takes
Subcutaneous . 106 . 12 . 10
Intralymphatic . 107 . 12 . 6
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The retention oftumour cells by the popliteal lymph node
The retention of tumour cells by the popliteal lymph node was compared in
untreated animals with those that had been treated with 3 doses ofintra-muscular
cortisone 25 mg., onthepreceding 2days, and4hoursbeforeinjection; comparisons
were made both immediately and 24 hours later, and retention was found to be
significantly less in treated animals (P < 0 001 in each case).
Immediately post injection
Untreated
Cortisone treated .
At 24 hours
Untreated
Cortisone treated.
No.
. 13 .
. 14 .
Mean value
56% (S.D. 6-49)
48% (S.D. 5 - 79)
* 18 . 32% (S.D. 6 36)
13 . 22% (S.D. 6 03)
The retention of tumour cells by the popliteal lymph node of the exercised
limb, passive exercises being carried out once a second for 5 minutes afterinjection,
was compared with that of the other limb kept at rest. Retention by the
exercised limb was significantly reduced (P < 0001).
At 24 hours No. Mean
Exercised . . . . 8 . 16% (S.D. 3 94)
At rest . . . . 8 . 29% (S.D. 2 60)
The complete readings ofthe retention oftumour cells by the popliteal lymph
node are shown in Fig. 1 and 2.
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FIG. 1.-The retention of Vx2 cells by the popliteal node in normal 0
and cortisone-treated X rabbits.
FIG. 2.-The retention of tumour cells by the popliteal node in exercised x and control 0 limbs.RETENTION OF TUMOUR CELLS IN LYMPH NODES
DISCUSSION
The observation that the popliteal lymph node of the rabbit fails to retain all
of a large number of radio-actively labelled tumour cells confirms that of Fisher
and Fisher (1967). However, in this series, it was found that, allowance being
made for elution of isotope, the majority of tumour cells immediately retained by
the node remained so for a 24-hour period. A previous series of experiments
showed that the regional lymph node would act as a temporary barrier to the
further spread oftumour growth; this was established by Zeidman, Copeland and
Warren (1954), with a similar animal model, who showed that excision of the
lymph node up to 3 weeks after injection of the Vx2 cell suspension, eliminated
the tumour. It seems probable, therefore, that those cells which transgress the
lymph node are less able to produce metastases than those trapped by it.
Cortisone therapy and limb exercise, two factors which produced enhanced
metastasis in these animals, also diminished the retention of tumour cells by the
lymph node, perhaps allowing the release of cells able to establish metastatic
growth.
Saldeen (1963) observed an increase in tumour cell incidence in thoracic duct
lymph of rats with Rous sarcoma of the thigh, treated with hydrocortisone.
Heller (1953) showed that the retention of colloidal chromium phosphate by
lymph nodes of cortisone treated rats was reduced. Dougherty and White (1945)
showed marked involutionary hyperplasia of lymph nodes ofrabbits on cortisone
therapy, and it has been possible to confirm this with these animals. It is
probablethat cortisoneexertsitseffectbyalteringboththestructural configuration
of the lymph node and its biological properties.
The disadvantage of this experimental model is that labelling the tumour
cells with radioactive chromium reduced their viability. Ludwig and Titus
(1967) showed, with small intra-lymphatic inoculations ofWalker 256 rat tumour
labelled with tritiated thymidine, that there was no conclusive evidence that cells
traversed the regional lymph node before metastases developed. Future projects
will study the retention of smaller quantities of Vx2 tumour cell emboli and the
distribution of cells which transgress the lymph node, using an alternative form
of radioactive cell tag.
SUMMARY
Anexperimental model hasbeen designedto estimate the abilityofthepopliteal
lymph node of the rabbit to retain radio-actively labelled Vx2 tumour cells
introduced into the afferent vessel. Their retention was incomplete and was
further reduced by prior treatment with cortisone and passive exercise of the
limb after tumour cell injection.
This work was carried out whilst the author was in receipt of a grant from the
British Empire Cancer Campaign for Research. He wishes to acknowledge the
generous help of Professor H. Ellis. He is grateful to Mr. P. Moore and other
staff of the Surgical Unit laboratories, Westminster Medical School, for technica
assistance.
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